Nippon India Pharma Fund (Bonus)
Sectoral FundNAV
568.91(0.35%)Fund Size (CR)
₹9,166.4Expense Ratio
1.83Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹Minimum Withdrawal
₹100Exit Load
1%Return Since Launch
19.72%
Basic Details
Scheme Manager
Sailesh Raj Bhan
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | October 28, 2026 | 10299.00 | 2.99% | - | 3.11% | 183/256 |
| 1 Month | October 1, 2026 | 10156.01 | 1.56% | - | 2.75% | 165/256 |
| 3 Month | August 4, 2026 | 9913.93 | -0.86% | - | -2.49% | 99/252 |
| 6 Month | May 4, 2026 | 10828.98 | 8.29% | - | 6.21% | 116/252 |
| 1 Year | November 4, 2025 | 10957.93 | 9.58% | 9.58% | 2.86% | 66/224 |
| 3 Year | November 3, 2023 | 16355.27 | 63.55% | 17.78% | 14.10% | 59/162 |
| 5 Year | November 3, 2021 | 18846.58 | 88.47% | 13.50% | 10.32% | 37/122 |
| Since Inception | June 5, 2004 | 566941.20 | 5569.41% | 19.72% | 12.29% | 34/254 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | December 1, 2025 | 1,20,000 | 128756.47 | 7.30% | 7.30% |
| 3 Year | December 1, 2023 | 3,60,000 | 418481.94 | 16.24% | 5.15% |
| 5 Year | December 1, 2021 | 6,00,000 | 885548.68 | 47.59% | 8.10% |
| 10 Year | December 1, 2016 | 12,00,000 | 2974390.07 | 147.87% | 9.50% |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Risk Ratios
4.35%
Standard Deviation
0.68%
Beta
0.76%
Sharpe Ratio
0.07%
Treynor's Ratio
12.14%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 11.71% | 5906349 | 1072.95 | Equity | Pharmaceuticals |
| Divi's Lab. | 7.10% | 700754 | 651.11 | Equity | Pharmaceuticals |
| Lupin | 6.17% | 2783991 | 565.21 | Equity | Pharmaceuticals |
| Cipla | 6.01% | 4095054 | 551.19 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 5.45% | 4049746 | 499.33 | Equity | Pharmaceuticals |
| Apollo Hospitals | 4.89% | 548795 | 448.12 | Equity | Healthcare |
| Mankind Pharma | 4.38% | 1603562 | 401.50 | Equity | Pharmaceuticals |
| Sai Life | 3.92% | 2355745 | 359.13 | Equity | Pharmaceuticals |
| Ajanta Pharma | 3.61% | 913918 | 330.91 | Equity | Pharmaceuticals |
| Glaxosmi. Pharma | 3.11% | 1029460 | 285.09 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Kotak Healthcare Fund - Direct (G) | 825.14 | 1.25% | 2.82% | 19.37% | 25.51% | - | |
| Kotak Healthcare Fund - Direct (IDCW) | 825.14 | 1.25% | 2.82% | 19.36% | 25.51% | - | |
| HDFC Pharma and Healthcare Fund - Direct (G) | 3501.37 | 2.30% | 2.51% | 17.12% | 25.49% | 31.02% | |
| HDFC Pharma and Healthcare Fund - Direct (IDCW) | 3501.37 | 2.30% | 2.51% | 17.12% | 25.49% | 31.02% | |
| SBI Automotive Opportunities Fund - Direct (G) | 6070.82 | 3.27% | -0.04% | 15.99% | 22.36% | - |
List of Schemes under Nippon India Mutual Fund
News
Nippon India Mutual Fund announces IDCW & Income Distribution cum Capital Withdrawal (IDCW) under its schemes
Nippon India Mutual Fund has announced July 10 2026 as the record date for declaration of IDCW under the following schemes. The proposed IDCW on the face value of Rs 10 per unit will be:Nippon India Balanced Advantage Fund - Regular Plan ' IDCW 0.2200
Nippon India Balanced Advantage Fund - Direct Plan ' IDCW: 0.2200
Nippon India Multi Asset Allocation Fund - Regular Plan ' IDCW 0.1500
Nippon India Multi Asset Allocation Fund - Direct Plan ' IDCW: 0.1500
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
May 10, 2004
Total AUM (Cr)
₹9166.40
Nippon India Pharma Fund (Bonus) is an Sectoral Fund-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in May 10, 2004, this fund is managed by Sailesh Raj Bhan. With assets under management (AUM) worth ₹9,166.4 (Cr), as of November 5, 2026, Nippon India Pharma Fund (Bonus) is categorized as a Sectoral Fund within its segment. The fund has generated a return of 19.72% since its launch.
The current NAV of Nippon India Pharma Fund (Bonus) is ₹568.91, as on November 5, 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in Nippon India Pharma Fund (Bonus) via both lumpsum and SIP modes. The minimum SIP amount in the fund is - while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 17.78% and 13.50% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 97.31% in Equity, 2.81% in Debt and -0.12% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 73.97% in Pharmaceuticals & Biotech, 20.27% in Healthcare Services, 2.81% in Debt, 2.53% in Retailing, 0.54% in Healthcare Equipment & Su
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors
FAQs
Nippon India Pharma Fund (Bonus) is a popular fund in the Sectoral Fund segment. The fund has generated a return of 19.72% since inception. Looking to invest in Nippon India Pharma Fund (Bonus) How about earning 1% extra return? All this is possible with m.Stock! Investing in Nippon India Pharma Fund (Bonus) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage on Mutual Funds, Delivery & IPO.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, Nippon India Pharma Fund (Bonus)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Use the Lumpsum Calculator to estimate returns, then enter the investment amount, select the payment mode mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route: Utilize the SIP Calculator to forecast potential growth, then enter the SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in Nippon India Pharma Fund (Bonus) today and reap the benefits of this Sectoral Fund fund!